The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
Open accessAbstract
which predominantly occurred in young males after the second dose, an ACIP meeting was rapidly convened to review reported cases of myocarditis and pericarditis and discuss the benefits and risks of mRNA COVID-19 vaccination in the United States. Myocarditis is an inflammation of the heart muscle; if it is accompanied by pericarditis, an inflammation of the thin tissue surrounding the heart (the pericardium), it is referred to as myopericarditis. Hereafter, myocarditis is used to refer to myocarditis, pericarditis, or myopericarditis. On June 23, 2021, after reviewing available evidence including that for risks of myocarditis, ACIP determined that the benefits of using mRNA COVID-19 vaccines under the FDA's EUA clearly outweigh the risks in all populations, including adolescents and young adults. The EUA has been modified to include information on myocarditis after receipt of mRNA COVID-19 vaccines. The EUA fact sheets should be provided before vaccination; in addition, CDC has developed patient and provider education materials about the possibility of myocarditis and symptoms of concern, to ensure prompt recognition and management of myocarditis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, our study confirms findings of previ ously identified rare cases of myocarditis and pericarditis following first and second doses of mRNA vaccines [21 -23,34].”
From COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals (2024) · cites this paper as [23]
Experimental — accuracy not yet measuredIn the citing paper
“In women aged 18–24, mRNA COVID-19 vaccination would prevent 1127 hospitalisations, 93 ICU admissions and 13 deaths, while causing 4–5 myocarditis cases. 25”
From Vaccine mandates for healthcare workers beyond COVID-19 (2023) · cites this paper as [25]
In the citing paper
“1 million mRNA COVID-19 vaccination doses would prevent 936 hospitalisations, 215 intensive care unit (ICU) admissions and 13 deaths, while simultaneously leading to 15–18 vaccine-associated myocarditis cases.”
From Vaccine mandates for healthcare workers beyond COVID-19 (2023) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cooper, L. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0800028 · Cited by 1,325
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Shimabukuro, T. T., Nguyen, M., Martin, D., & Destefano, F. R. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.035 · Cited by 627
Self-citationPreliminary evidence on long COVID in children
Buonsenso, D., Munblit, D., Rose, C. D., Sinatti, D., Ricchiuto, A., Carfì, A., & Valentini, P. (2021) · Acta Paediatrica · doi:10.1111/apa.15870 · Cited by 508
Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2
Payne, A. B., Gilani, Z., Godfred‐Cato, S., Belay, E. D., Feldstein, L. R., Patel, M. M., Randolph, A. G., Newhams, M. M., Thomas, D., Magleby, R., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.16420 · Cited by 395
Self-citationThe Vaccine Safety Datalink: A Model for Monitoring Immunization Safety
Baggs, J. M., Gee, J. M., Lewis, E. M., Fowler, G. L., Benson, P. J., Lieu, T. A., Naleway, A. L., Klein, N. P., Baxter, R. P., Belongia, E. A., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1722h · Cited by 349
Self-citationThe effects of gender and age on occurrence of clinically suspected myocarditis in adulthood
Kytö, V., Sipilä, J., & Rautava, P. (2013) · Heart · doi:10.1136/heartjnl-2013-304449 · Cited by 124
Trends in Acute Myocarditis Related Pediatric Hospitalizations in the United States, 2007–2016
Vasudeva, R., Bhatt, P. J., Lilje, C., Desai, P., Amponsah, J. K., Umscheid, J., Parmar, N. G., Bhatt, N. S., Adupa, R., Pagad, S., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.03.019 · Cited by 53
Cited by
Sorted by citations
Items 501–586 of 586
Therapeutic Modalities for Coronavirus SARS-CoV-2 (COVID-19)
(2022) · Advances in Hematology and Oncology Research · doi:10.33140/ahor.05.01.06
Katoto, P. D., Kakubu, M. A., Tamuzi, J. L., Brand, A., Ayuk, A. C., Byamungu, L. N., Wiysonge, C. S., & Gray, G. (2023) · medRxiv · doi:10.1101/2023.01.20.23284812
Myopericarditis After BNT162b2 mRNA Vaccination With Incidental Intramyocardial Bridging
Elghazal, M. M., Alhudiri, I. M., Said, M. H., Elhouderi, E., & Elzagheid, A. I. (2023) · Cureus · doi:10.7759/cureus.34452
COVID-19 vaccine-associated myocarditis (Russian translation)
Morgan, M. C., Atri, L., Harrell, S., AlJaroudi, W., & Berman, A. E. (2022) · Juvenis scientia · doi:10.32415/jscientia_2022_8_6_41-55
Mohi, G. K., Yadav, B., Singh, S., & Thakur, N. (2023) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.17.1.48
Chae, S. H., Park, H., Radnaabaatar, M., Park, H., & Jung, J. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e94
The First Ethiopian Case Report of Post-Covid-19 Vaccine Associated Guillain-Barre Syndrome
Demissie, Z. (2022) · Neurons and Neurological Disorders · doi:10.58489/2836-8851/002
Epidemiology and Control: From Principles to Pandemics
Kaslow, R. A., & Bell, D. M. (2023) · Springer eBooks · doi:10.1007/978-1-4939-9544-8_1-2
Acute Myocarditis after Pfizer-BioNTech COVID-19 m-RNA Vaccination
Nastevska, E. G., Andova, V., Zafirovska, P., Kandic, E., Chelikikj, A., Vrajnko, E., Jovchevska, S., Bushljetikj, O., ZİMBAKOV, Z., Spiroski, I. M., et al. (2022) · South East European Journal of Cardiology · doi:10.3889/seejca.2022.6032
Destefano, F. R., Fisher, A., Shimabukuro, T. T., & Offit, P. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00083-9 · Cited by 1
Self-citationCOVID-19 Vaccine–Associated Myocarditis Considerations for Competitive Athletes
Tso, J., & Kim, J. H. (2023) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-023-01009-z
Wang, Y. (2023) · International Conference on Modern Medicine and Global Health (ICMMGH) · doi:10.1117/12.2692443
Chekaoui, A., Novikov, M., Xiang, Z., Hasanpourghadi, M., Ambrose, R., Chekaoui, A., Newman, D., Giles‐Davis, W., & Zhou, X. (2023) · Research Square · doi:10.21203/rs.3.rs-3314638/v1
Myocarditis Associated with mRNA COVID-19 Vaccination
Yasuda, K. (2022) · Japanese Society of Pediatric Cardiology and Cardiac Surgery · doi:10.9794/jspccs.38.186
Experience in the use of vaccine Gam-Kovid-Vak-M for the prevention of COVID-19 in children
Chernova, Т. М., Иванов, Д. О., Тимченко, В. Н., Михайловна, Х. С., Балакина, М. Е., Miroshnikova, Y. K., Баракина, Е. В., Павлова, Е. Б., Morozova, A. V., Myskina, N. A., et al. (2023) · CHILDREN INFECTIONS · doi:10.22627/2072-8107-2023-22-3-33-38
Sarbazi, E., Masoudi, N., Mehri, A., Mehdizadeh, R., Azizi, H., Pouraghaei, M., & Soleimanpour, H. (2023) · Research Square · doi:10.21203/rs.3.rs-3425080/v1
Post-vaccine COVID-19 acute myocarditis: Case report
Benhlima, A. (2023) · Open Journal of Clinical and Medical Case Reports · doi:10.52768/2379-1039/2052
Formanek, A., Wagner, T., Newrkla, S., & Kurz, H. (2023) · Pädiatrie & Pädologie · doi:10.1007/s00608-023-01148-3
Nanoscale Vaccines for the Prevention of COVID-19
Iqbal, M. J., Hamdani, T., Attarwala, H. Z., & Amiji, M. M. (2023) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-031-39020-3_13
Two Swords in the Storm: Parvovirus B19 and COVID-19 Clash in a Myocardial Mayhem of Arrhythmias
Khalikh, S. A. K. A., & Munde, K. S. (2023) · Cardiology and Angiology An International Journal · doi:10.9734/ca/2023/v12i4376
Han, H., Zhao, D., Fang, X., Yang, W., Wang, M., Liu, Q., Wang, L., Ji, Z., Zhang, J., Hou, Z., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2152063/v3
COVID-19 vaccine-associated adverse effects; benefits outweigh the risks?
Kibar, B. S., & Özdemır, Ö. (2023) · JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH · doi:10.34084/bshr.1367181
Kalp Kapak Hastalıkları ve Spor Kardiyolojisi
Özyıldırım, S. (2023) · doi:10.5152/0105
Ritim Bozuklukları ve Spor Kardiyolojisi
Aslan, Ş., & Yıldız, M. (2023) · doi:10.5152/0109
Perikardit ve Spor Kardiyolojisi
Coşkun, O. (2023) · doi:10.5152/0107
Fonksiyonel Tıp ve Spor İlişkisi
Yıldız, M. (2023) · doi:10.5152/0113
Altan, M. (2023) · doi:10.5152/0102
Kronik Koroner Sendromlar ve Spor Kardiyolojisi
Si̇nan, Ü. Y. (2023) · doi:10.5152/0104
Erişkin Doğumsal Kalp Hastalıkları ve Spor Kardiyolojisi
Gürsoy, M. O., & Yıldız, M. (2023) · doi:10.5152/0110
Miyokardit ve Spor Kardiyolojisi
Dinçer, Ş. (2023) · doi:10.5152/0108
Kardiyomiyopatiler ve Spor Kardiyolojisi
Barman, H. A. (2023) · doi:10.5152/0106
Aortopati ve Spor Kardiyolojisi
Kahraman, S., & Yıldız, M. (2023) · doi:10.5152/0111
Kardiyovasküler Sistem ve Egzersiz
Sönmez, O. F. (2023) · doi:10.5152/0101
Spor Kardiyolojisi ve Kalp Damar Hastalıkları
Barman, H. A., Alttan, M., Gürsoy, M. O., Yıldız, M., Coşkun, O., Sönmez, O. F., Demi̇r, R., Özyıldırım, S., Kahraman, S., Dinçer, Ş., et al. (2023) · doi:10.5152/0100 · Cited by 4
Yıldız, M. (2023) · doi:10.5152/0112
Han, H., Zhao, D., Fang, X., Yang, W., Wang, M., Liu, Q., Wang, L., Ji, Z., Zhang, J., Hou, Z., et al. (2023) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2288630
Han, H., Zhao, D., Fang, X., Yang, W., Wang, M., Liu, Q., Wang, L., Ji, Z., Zhang, J., Hou, Z., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2152063/v4
Alami, A. (2023) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2023-15810
Khawcharoenporn, T., & Hanvivattanakul, S. (2023) · International Journal of STD & AIDS · doi:10.1177/09564624231220090
Case Report of Myopericarditis post COVID-19 Vaccinations in the first female young adult in MS
Nair, V., Byers, P., & Taylor, K. G. (2022) · Journal of Public Health in the Deep South · doi:10.55533/2996-6833.1018
Slater, K. M., Buttery, J. P., Crawford, N. W., & Cheng, D. R. (2024) · Communicable Diseases Intelligence · doi:10.33321/cdi.2024.48.18
COVID-19 Vaccines: A Radiological Review of the Good, the Bad, and the Ugly
Kumar, I., Ansari, M. S., Verma, A. K., Singh, P. K., Chakrabarti, S. S., & Shukla, R. C. (2024) · Indian journal of radiology and imaging - new series/Indian journal of radiology and imaging/Indian Journal of Radiology & Imaging · doi:10.1055/s-0044-1785210
COVID-19 VE KARDİYOVASKÜLER SİSTEME ETKİLERİ
URKMEZ, F. Y., & Polat, E. (2024) · Kocatepe tıp dergisi. · doi:10.18229/kocatepetip.1100443
A Case Report on COVID-19 Vaccination Induced Heart Failure
Rajan, B. C. R. (2023) · International Journal of Science and Research (IJSR) · doi:10.21275/sr23624115957
She, C.-H., Tsang, H.-W., Yang, X.-T., Tsao, S., Tang, C. S., Chan, S. H. S., Kwan, M. Y., Chua, G. T., Yang, W., & Ip, P. (2024) · BMC Genomic Data · doi:10.1186/s12863-024-01238-6
Forsdyke, D. R. (2024) · Qeios · doi:10.32388/mlp1tn.4
Zahrani, E. A., Elsafi, S. H., Alkharraz, R., Sahal, N., Almansori, M., Alhababi, A., & Alkharraz, Z. S. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s467586
Insights from assessment for arrhythmia after CoViD-19 vaccination among Indians
Sunita, S., Negi, M. B., Lal, M., Kumar, C., & Kumar, M. (2024) · Bioinformation · doi:10.6026/973206300200430
Loedy, N., Dorta, H. G., Abrams, S., Crèvecoeur, J., Morales, D. R., Cohet, C., Willem, L., Molenberghs, G., Hens, N., Kurz, X., et al. (2024) · medRxiv · doi:10.1101/2024.08.09.24311669
Impact of the COVID-19 pandemic on patients with primary immunodeficiency
Nijhawan, P., Sharfe, N., Dadi, H., & Vong, L. (2024) · LymphoSign Journal · doi:10.14785/lymphosign-2024-0007
Behcet's disease-related panuveitis following COVID-19 vaccination: A case report
Lin, R.-T., Liu, P., Chang, C.-W., Cheng, K., Chen, K., & Chang, Y. (2024) · World Journal of Radiology · doi:10.4329/wjr.v16.i9.460
The role of COVID-19 vaccination
Lin, E. Y., Behrouzi, B., & Udell, J. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14001-3.00015-7
Long-term clinical outcomes and prognosis
Molinari, L. V., Ricci, F., Gallina, S., Fedorowski, A., & Chahal, C. A. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14001-3.00012-1
Long-Term Prognosis of Patients With Myocarditis—Reply
Semenzato, L., Vu, S. L., & Zureik, M. (2025) · JAMA · doi:10.1001/jama.2024.25766
Long-Term Prognosis of Patients With Myocarditis
Yang, C., & Tebbutt, S. J. (2025) · JAMA · doi:10.1001/jama.2024.25763
Molinari, R. W. R. M., Silvério, L. D., Faria, L. F. V., Silva, V. H. R., Montevechi, L. C., & Silvério, A. D. S. D. (2025) · Journal Archives of Health · doi:10.46919/archv6n1-004
Ali, M. T., Chapra, A. F., Mohamed, S., Ghareeb, A. N., Kuwari, M. A., Karim, S. A., Hamid, T., Hassan, E. A. A., Qahtani, A. A., Asaad, N., et al. (2024) · Heart Views · doi:10.4103/heartviews.heartviews_62_24
Dennehy, P. H., Holland, S., Köster, M., & Rogo, T. O. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00262-4
Vallejo, J. G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00028-5
Menstrual Irregularities after COVID-19 Vaccination: Exploring the Hindrances in Vaccine Compliance
Verma, V., Sinha, P., Kanti, V., Singh, A. P., Priyadarshini, A., & Meena, S. (2025) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2586
(Constrictive pericarditis after SARS-CoV-2 vaccination: a case report and literature review)
Simovicova, V., Danková, M., Drangová, E., Hulman, M., & Gonçalvesová, E. (2025) · Cor et Vasa · doi:10.33678/cor.2024.107
Zwiers, L. C., Grobbee, D. E., Schneijdenberg, R., Baljé, C., Laurent, S. S., Esposito, D. B., Zhu, L., Urdaneta, V., Emile-Backer, M., Weibel, D. M., et al. (2025) · Vaccines · doi:10.3390/vaccines13070755
Yusuf, O., Omotosho, A. O., Moore, S., & Khan, A. (2025) · Cureus · doi:10.7759/cureus.88611
Ertl, H. C. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29979-7.00013-1
Severe TRALI Following Postvaccination MIS-C in a Young Female
Piastra, M., Portaccio, I., Buonsenso, D., Picconi, E., Morena, T. C., Tosi, F., & Conti, G. (2025) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004952
Gobezie, M., Merawie, D. M., & Dagnaw, M. (2025) · Discover Public Health · doi:10.1186/s12982-025-00753-w
Demir, V. M., & Aslan, B. C. (2025) · Temaşa Erciyes Üniversitesi Felsefe Bölümü Dergisi · doi:10.55256/temasa.1757698
She, C. H., Tsang, H. W., Yang, X., Tsao, S. S., Tang, C. S.-M., Chan, S. H., Kwan, M. Y. W., Chua, G. T., Yang, W., & Ip, P. (2024) · Figshare · doi:10.6084/m9.figshare.25989335
She, C. H., Tsang, H. W., Yang, X., Tsao, S. S., Tang, C. S.-M., Chan, S. H., Kwan, M. Y. W., Chua, G. T., Yang, W., & Ip, P. (2024) · Figshare · doi:10.6084/m9.figshare.26730463
She, C. H., Tsang, H. W., Yang, X., Tsao, S. S., Tang, C. S.-M., Chan, S. H., Kwan, M. Y. W., Chua, G. T., Yang, W., & Ip, P. (2024) · Figshare · doi:10.6084/m9.figshare.26730466
She, C. H., Tsang, H. W., Yang, X., Tsao, S. S., Tang, C. S.-M., Chan, S. H., Kwan, M. Y. W., Chua, G. T., Yang, W., & Ip, P. (2024) · Figshare · doi:10.6084/m9.figshare.25989251
Nanochemistry in Vaccine Delivery: Lipid Nanoparticles, Polymers, and Hybrid Systems
Chandipwisa, C., Shimilimo, A., Zenda, T., & Banda, H. (2026) · Sciences of Pharmacy · doi:10.58920/sciphar0501525
Benucci, M., Cioffi, E., Gobbi, F. L., Cassarà, E. A. M., Terenzi, R., Russo, E., Grossi, V., Lari, B., Infantino, M. G., & Manfredi, M. (2026) · Antibodies · doi:10.3390/antib15020024
Inflammation and Heart Failure
Kim, K., Kim, D., & Eisen, H. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-12629-0_20
Ambivalent Safeties: Attending to Intersectional Marginalities in Vaccine Pharmacovigilance
Mezza, M. (2026) · Springer eBooks · doi:10.1007/978-981-95-8349-2_6
mRNA vaccines against viral pathogens: molecular design, delivery systems, and clinical applications
Xu, W., Wang, J., Liu, X., Lü, M., Zhang, Z. K., & Li, L. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1821852
Gould, S., & Londoño-Hayes, P. (2026) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2026.106133
Tulisibaike, B., Yang, T.-Y., Gu, W., Liu, H., Wang, Y., Yang, J.-Q., Wang, T., Ding, S.-M., Cai, R.-X., Wang, Y., et al. (2026) · Vaccines · doi:10.3390/vaccines14060524
Known Vaccine-Associated Adverse Events
Tilak, K., Adams, F., & Harrison, C. J. (2026) · Springer eBooks · doi:10.1007/978-1-0716-5464-4_3
Committee on Infectious Diseases (2026) · PEDIATRICS · doi:10.1542/peds.2026-079046
Vaccines, Disinformation, & the Legacy of Maurice Hilleman
Silva, H. M. (2026) · The American Biology Teacher · doi:10.1525/abt.2026.88.7.377
Summary of 2025 Society of Toxicology Workshop “Vaccine Toxicology in the Post-COVID Era”
Gould, S., Rohde, C. M., Destexhe, É., Tiesjema, B., & Segal, L. M. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.129180
Alidema, F. B., & Alidema, A. H. (2026) · Central European Journal of Public Health · doi:10.21101/cejph.a8953
Metadata
- Authors
- Gargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., Broder, K. R., Gee, J., Weintraub, E., Shimabukuro, T., Scobie, H. M., Moulia, D., Markowitz, L. E., Wharton, M., McNally, V. V., Romero, J. R., Talbot, H. K., Lee, G. M., Daley, M. F., & Oliver, S. E.
- Affiliations
- Kaiser Permanente (US)
- Corresponding author
- Gargano, Julia W.
- ORCID
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2021-07-09
- Volume
- 70
- Issue
- 27
- Pages
- 977-982
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- PMC
- PMC8312754
- OpenAlex
- W3178327314
- Cited by
- 587
- References
- 7
- Citations by year
- 2026: 18 · 2025: 33 · 2024: 66 · 2023: 138 · 2022: 239 · 2021: 92
- FWCI
- 89.67
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- U.S. Department of Health and Human Services
- Minnesota Department of Health
- Council of State and Territorial Epidemiologists
- Kaiser Permanente
- Vanderbilt University
- Emory University
- George Washington University
- Nationwide Children's Hospital
- University of Washington
- Johns Hopkins University (COVID-19)
- Drexel University
- American Pharmacists Association
- Saint Louis University
- Public Health Agency of Canada
- Marshfield Clinic Research Institute
- Kaiser Permanente Washington Health Research Institute
- Northwell Health
- Public Health Agency
- National Institutes of Health (COVID-19)
- Centers for Disease Control and Prevention
- School of Medicine, Vanderbilt University
- University of California, Los Angeles
- College of Medicine, Drexel University
- Wake Forest School of Medicine
- Research Institute, Nationwide Children's Hospital
- Biomedical Advanced Research and Development Authority
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- COVID-19 mRNA vaccine, myocarditis, pericarditis, myopericarditis, vaccine safety, Advisory Committee on Immunization Practices, emergency use authorization, adolescents and young adults, patient and provider education
- MeSH terms
- COVID-19, COVID-19 Vaccines, mRNA Vaccines, Adolescent, Adult, Centers for Disease Control and Prevention, U.S., Child, Female, Humans, Immunization, Male, Myocarditis, United States, Vaccines, Synthetic, Adverse Drug Reaction Reporting Systems, Practice Guidelines as Topic, Advisory Committees, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
